This Week in MMWR: Vol. 73, March 28, 2024
March 28, 2024
In this IssueSickle cell disease, social vulnerability—11 statesCeftriaxone-resistant gonorrhea — ChinaImplications of measles inclusion, PCR panelsTuberculosisUpdated COVID-19 vaccine effectiveness, immunocompromised adults
WEEKLY REPORT
Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability
During 2016-2020, 2 of 3 newborns with sickle cell disease were born to mothers who live in U.S. counties with high levels of social vulnerability.
Ceftriaxone-Resistant Gonorrhea
The prevalence of antibiotic-resistant strains of Neisseria gonorrhoeae increased in China during 2017-2022. Resistance to ceftriaxone, the first-line treatment for gonorrhea, nearly tripled.
Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels
During the first year of measles inclusion in commercial syndromic polymerase chain reaction panels, approximately 1% of tests reported a positive measles test result after recent routine childhood measles, mumps, and rubella (MMR) vaccination.
Tuberculosis
While the U.S. maintains one of the lowest tuberculosis (TB) incidence rates in the world, TB cases in the U.S. increased to 9,615 cases in 2023, compared to 8,895 in 2019.
Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions
During September 2023–February 2024, adults with weakened immune systems who received an updated COVID-19 vaccine were about one-third less likely to be hospitalized with COVID-19 compared with those who had not received an updated COVID-19 vaccine.READ THE WEEKLY REPORTS
PDF of this issue (link)
CONTINUING EDUCATION
A new, free CE from MMWR and Medscape discusses trends in U.S. cannabis-involved emergency department visits in people younger than age 25 during the COVID-19 pandemic.EARN FREE CE
PODCAST
MMWR Weekly Briefing Podcast: Week of March 4
The latest MMWR Weekly Briefing is live. Topics include: effectiveness of nirsevimab against RSV hospitalization in young children, emergency department visits for melatonin ingestion in children, and more. Listen and subscribe on: Apple Podcasts, Spotify, and Google Play.LISTEN NOW
Centers for Disease Control and Prevention
1600 Clifton Rd Atlanta, GA 30329 1-800-CDC-INFO (800-232-4636) TTY: 888-232-6348Questions or Problems | Unsubscribe
